1/28
Looks like no tags are added yet.
Tobacco
Nicotine is the psychoactive ingredient in tobacco (natural)
Dried tobacco leaves contain 5% nicotine
Tobacco smoke is complex:
Nicotine, Carbon monoxide, Tar (carried nicotine to lungs; many particulates are carcinogenic)
History of Tobacco Use
Ancient:
Brought to Europe by Columbus ; popular in 1500-1600s
Recent:
Cigarettes became dominant form of consumption in 20th century ; due to new curing methods & invention of cigarette machine
U.S. Tobacco Use
Decline in cigarette smoking since 1960s
About 20% of U.S. adults are current users of tobacco products
About 30% of high-school students are users
Policies on U.S. Tobacco Use
Dangers of secondhand smoke slowly led to smoking bans in public places
2016: FDA began to regulate all tobacco products, including e-cigarettes
E-cigarettes are not safe
2019: increased the age to buy tobacco products from 18 to 21
Worldwide Tobacco Use
Nicotine is 3rd most widely consumed recreational drug in the world (behind caffeine & alcohol)
Tobacco use kills ~ 9 million/year
Pharmacokinetics: Routes of Nicotine Administration
Smoking/vaporizing (“vaping”):
Nicotine carried on tar or other particles ; Absorbed via lungs ; Provides highest blood nicotine
By mouth (chew, dip, snus):
Absorbed by membranes in mouth (swallowing not effective, strong first pass metabolism)
By nose (snuff):
Absorbed by membranes in nose
Teens more likely to use e-cigarettes than cigarettes
Electronic Nicotine Delivery System (ENDS): electronic devices that vaporize liquid
Smoking/vaping gives fast onset & short duration (7 second onset)
Smoking/Vaping in High School Students
Decreased cigarette use over last 10 years
Increased vaping for nicotine & THC
Vaping in College-age Adults
Marijuana/Cannabis vaping: increasing among college students & non-college peers
Nicotine vaping: increasing among college students & non-college peers
In 2024, non-college peers were vaping cannabis & nicotine at higher rates than college students
Pharmacokinetics: Nicotine Metabolism
Nicotine mostly metabolized into cotinine by cytochrome P450 enzyme in liver
Individual variation in expression of this enzyme:
Half-life of nicotine averages at 2 hours but varies among individuals
People w/ reduced nicotine metabolism are less likely to become smokers
Nicotine Mechanism of Action
Pharmacodynamic Action:
Nicotine is agonist at nicotinic acetylcholine receptors (nAChRs), which are ionotropic receptors found in:
Brain & spinal cord
Autonomic nervous system (in PNS)
Neuromuscular Junction, NMJ (in somatic nervous system)
Nicotine Effects on Arousal
Although smokers find smoking relaxing, nicotine is a stimulant
Nicotine Stimulant Effects:
Experienced drug users will sometimes misidentify IV nicotine as cocaine
Sometimes see cross-substitution w/ cocaine
Nicotine enhances locomotor activity in animals, & shows sensitization
Nicotine Effects on Cognition
Acetylcholine (ACh) is implicated in cortical function related to sustained attention & memory
Nicotine can enhance performance on attention-demanding tasks
In smokers, only restores performance to level of non-smokers
Rat studies show enhanced performance on cognitive tasks with nicotine
Nicotine Effects on Mood
Relaxing, Alleviates stress, Helps concentration
Partially associated w/ relief from withdrawal - maintain steady level of nicotine levels to avoid withdrawal
1st cigarette in morning is most pleasurable
Smokers often can’t tell difference between nicotine & denicotinized cigarettes
Prefer to smoke denicotinized cigarettes than take i.v. nicotine infusions
Nicotine effects at high doses:Toxicity
High Dose: Produces unpleasant symptoms (nausea, dizziness, sweating, etc.)
largely due to autonomic actions of nicotine (But there’s strong tolerance to these)
Lethal Dose (rare): Kills through depolarization block of muscles involved in respiration
Can be potent poison & insecticide
Nicotine Dependence & Withdrawal
Withdrawal symptoms are opposite at acute drug effects
Regular smokers feel irritability, stress, difficulty concentrating when they don’t smoke
or interval between cigarettes becomes too long
Nicotine Tolerance
Acute Tolerance: Develops over course of the day
due to desensitization of nicotinic receptors (nAChR)
Chronic Tolerance: Lasts long after smoking cessation
particularly to the aversive effects (lightheadedness, dizziness, nausea)
Pharmacodynamic Tolerance: nAChRs have decreased function
Negative Effects of Chronic Use
Smoking during pregnancy causes low birthweight
Half of all lifetime smokers die prematurely due to smoking-induced disease (~10 yrs sooner)
Increased risk for lung diseases, also cardiovascular diseases & cognitive deficits
ACh: Synthesis & Degradation
Synthesis: precursor for acetylcholine (ACh) is choline (vitamin found in many foods)
Choline acetyl-transferase (ChAT) is the enzyme that synthesizes ACh
Degradation: Acetylcholinesterase (AChE) metabolizes ACh into choline & acetic acid
Acetylcholine: Central Actions
Neurons in multiple brain systems:
Striatum: regulate responses to DA
Basal forebrain: cognition
Dorsolateral Pons: arousal/sensory
ACh: Synaptic Transmission
Packaged into vesicles by vesicular acetylcholine transporter (VAChT)
ACh inactivated via metabolism & then uptake
ACh undergoes rapid degradation/metabolism by AChE, converting it back to choline
Choline then taken up by choline transporter & reused to make more ACh
ACh: Notable Drugs
Receptor Agonists: Muscarine (mAChR) & Nicotine (nAChR)
mAChR antagonists used to treat post-surgery nausea & vomiting, motion sickness, & seasickness
Drugs Affecting ACh Release: Botulinum toxin (blocks ACh release) & Black widow spider venom (causes massive ACh release)
AChE Blockers: Physostigmine (reversible; treat anticholinergic poisoning) & Nerve gases/insecticides (irreversible; acts at autonomic system & muscles) Used to treat myasthenia gravis (treatment w/ synthetic analogs of physostigmine)
ACh: Receptors
Muscarinic ACh Receptors (mAChRs):
Metabotropic (GPCRs) ; named after muscarine found in certain toxic mushroom species
Nicotinic ACh Receptors (nAChRs):
Ionotropic (ion channels) ; named after selective agonist nicotine
Muscarinic ACh Receptors
5 types (M1-M5) coupled to Gq or Gi (metabotropic)
Serve various functions in CNS
Present in heart, organs, pancreas
Nicotinic ACh Receptors
Pentameric (5 subunits) ligand-gated cation channel; Combine in multiple ways in brain & muscle
Brain nAChRs: Consists of 2 alpha & 3 beta subunits ; higher binding affinity than periphery
Muscle nAChRs: 2 ACh binding sites (both need to be bound for channel opening)
Postsynaptic: rapid depolarization (EPSPs), which can increase neuronal firing or contract muscle
Presynaptic (axon terminal): enhance release of NTs
Desensitization: nAChRs desensitize w/ continuous exposure to agonist (channel closes) (reversible) Causes acute tolerance to nicotine
Nicotine Reinforcement: Increased DA Firing
Nicotine increases firing activity of DA cells in VTA & causes more DA release at terminals in nucleus accumbens (NAc)
Nicotine is self-administered by animals
Destroying DA terminals in the NAc with 6-OHDA greatly reduces nicotine self-administration
Nicotine Effects: nAChR Subtypes
alpha4 beta2 - containing receptors involved in rewarding effects of nicotine
alpha7 - containing receptors involved in cognitive (attention) effects of nicotine
Humans: Smoking leads to occupancy of alpha4 beta2 nAChRs, displacing PET ligand for up to 3.1 hours
Mice: IV nicotine self-administration impaired in mutant mice w/ genetic knockout of either alpha4, alpha6, or beta2 but not alpha7
Rats: MLA, but not DHbetaE, blocked nicotine effects on attention
Menthol Effects on Nicotine
Flavoring makes it easier to start smoking, harder to quit
Intensified nicotine withdrawal symptoms
Increases alpha4 beta2 nAChRs (even w/o nicotine)
Quitting Smoking
~70-75% of smokers say they would like to quit
~40-45% of smokers attempt to quit each year
<10% of attempts are successful (comparable to heroine success rates)
Replacement can help by reducing withdrawal symptoms, but high rates of relapse
Treatment Options
Nicotine Replacement Therapy (NRT): helps w/ dependence & withdrawal (gum, patch, etc.)
Others target withdrawal & craving:
Buproprion: DAT blocker, weak nAChR antagonist
Varenicline: partial agonist at alpha4 beta2 (most effective treatment)